San Diego, CA, United States of America

Frederick F Van-Goor

This inventor holds 1 USPTO granted patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick F Van-Goor. Retrieved from https://idiyas.com/inventor/frederick-f-van-goor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Frederick F Van-Goor

Introduction

Frederick F Van-Goor is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the modulation of ATP-binding cassette transporters. His work has implications for treating diseases related to these transporters, including cystic fibrosis.

Latest Patents

Frederick F Van-Goor holds 1 patent for his invention titled "Modulators of ATP-binding cassette transporters - 4-amido-pyrimidine compounds, derivatives and compositions thereof." This patent describes synthetic methods that are useful for modulating ATP-Binding Cassette ('ABC') transporters or fragments thereof. The invention also relates to methods of treating ABC transporter-mediated diseases using such modulators.

Career Highlights

Frederick is currently associated with Vertex Pharmaceuticals, Inc., a leading company in the biotechnology sector. His work at Vertex focuses on developing innovative therapies that target genetic diseases.

Collaborations

Some of his notable coworkers include Sara Sabina Hadida Ruah and Anna Hazlewood, who contribute to the collaborative environment at Vertex Pharmaceuticals.

Conclusion

Frederick F Van-Goor's innovative work in biotechnology exemplifies the impact of scientific research on healthcare. His contributions are paving the way for new treatments for serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…